GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (FRA:TPM0) » Definitions » Institutional Ownership

Tonix Pharmaceuticals Holding (FRA:TPM0) Institutional Ownership : 1.36% (As of May. 18, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tonix Pharmaceuticals Holding Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's institutional ownership is 1.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tonix Pharmaceuticals Holding's Float Percentage Of Total Shares Outstanding is 100.00%.


Tonix Pharmaceuticals Holding Institutional Ownership Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Institutional Ownership Chart

Tonix Pharmaceuticals Holding Historical Data

The historical data trend for Tonix Pharmaceuticals Holding can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31
Institutional Ownership 10.80 9.35 10.04 10.04 6.08 6.30 3.68 3.36 1.36 1.36

Tonix Pharmaceuticals Holding Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Tonix Pharmaceuticals Holding (FRA:TPM0) Business Description

Traded in Other Exchanges
Address
26 Main Street, Suite 101, Chatham, NJ, USA, 07928
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (FRA:TPM0) Headlines

No Headlines